Clinical Trial Update: Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children [NA]

View source ↗

Summary

A pediatric trial evaluating the link between non-alcoholic fatty liver disease and atherosclerotic risk in overweight/obese children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity

Snippet

Sponsor: Augusta University | Conditions: Overweight and Obesity, Non-alcoholic Fatty Liver Disease | NA | Status: COMPLETED